FDA Proposes Simplifying COVID Vaccine Schedule
The U.S. Food and Drug Administration (FDA) has proposed creating
a yearly COVID vaccine schedule, like the flu vaccine schedule. A yearly schedule
would simplify and normalize the COVID vaccine schedule. Similar to the way the
flu vaccine is handled, the COVID vaccine would try to predict and match whatever
variant will be circulating in the upcoming winter. The hope is that the public
could receive their COVID shot at the same time they receive their flu shot.
The proposed schedule would also eliminate the two-shot primary series
for most unvaccinated people, in favor of a mainstreamed program. However, older,
high-risk and immunocompromised Americans could still be recommended to get two
shots a year, as could young children when they reach the age eligible for vaccinations.
The FDA will not make any final decisions until late February
after a panel of experts at the Centers for Disease Control and Prevention (CDC)
has a similar public discussion on the newly proposed schedule. After which, both
the FDA and CDC will likely release finalized reports, leading to the CDC releasing
a new COVID vaccine schedule. The new COVID vaccine schedule will likely go into effect in the fall.